Document Detail

Serious adverse drug events reported to the Food and Drug Administration, 1998-2005.
MedLine Citation:
PMID:  17846394     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: The US Food and Drug Administration has operated the Adverse Event Reporting System since 1998. It collects all voluntary reports of adverse drug events submitted directly to the agency or through drug manufacturers. METHODS: Using extracts published for research use, we analyzed all serious adverse drug events and medication errors in the United States reported to the Food and Drug Administration from 1998 through 2005. RESULTS: From 1998 through 2005, reported serious adverse drug events increased 2.6-fold from 34 966 to 89 842, and fatal adverse drug events increased 2.7-fold from 5519 to 15 107. Reported serious events increased 4 times faster than the total number of outpatient prescriptions during the period. In a subset of drugs with 500 or more cases reported in any year, drugs related to safety withdrawals accounted for 26% of reported events in that group in 1999, declining to less than 1% in 2005. For 13 new biotechnology products, reported serious events grew 15.8-fold, from 580 reported in 1998 to 9181 in 2005. The increase was influenced by relatively few drugs: 298 of the 1489 drugs identified (20%) accounted for 407 394 of the 467 809 events (87%). CONCLUSIONS: These data show a marked increase in reported deaths and serious injuries associated with drug therapy over the study period. The results highlight the importance of this public health problem and illustrate the need for improved systems to manage the risks of prescription drugs.
Thomas J Moore; Michael R Cohen; Curt D Furberg
Related Documents :
12946244 - Detection of drug-related adverse events in hospitals.
8739024 - Pharmacokinetics and pharmacodynamics of multiple-dose terbinafine.
2937504 - Adverse drug reactions to first- and second-generation antidepressants: a critical eval...
18558794 - Influence of regulatory measures on the rate of spontaneous adverse drug reaction repor...
14988754 - Pharmacology of irinotecan.
11144704 - Treatment and prevention of otitis media.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Archives of internal medicine     Volume:  167     ISSN:  0003-9926     ISO Abbreviation:  Arch. Intern. Med.     Publication Date:  2007 Sep 
Date Detail:
Created Date:  2007-09-11     Completed Date:  2007-10-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372440     Medline TA:  Arch Intern Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1752-9     Citation Subset:  AIM; IM    
Institute for Safe Medication Practices, 1800 Byberry Rd, Ste 810, Huntingdon Valley, PA 19006, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adverse Drug Reaction Reporting Systems / statistics & numerical data*
Age Distribution
Drug Hypersensitivity / epidemiology*
Middle Aged
Pharmaceutical Preparations
Retrospective Studies
Sex Distribution
United States / epidemiology
United States Food and Drug Administration*
Reg. No./Substance:
0/Pharmaceutical Preparations

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  White matter lesions and the risk of incident hip fracture in older persons: results from the proget...
Next Document:  The variability and quality of medication container labels.